Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 12/20 | 0.42 |
| ▸ | AKT2 | P31751 | 11/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | NR1I3 | Q14994 | 2/20 | 0.34 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17658809 | 0.93 | AKT2 (0.47) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL17658810 | 0.93 | AKT2 (0.47) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL17658807 | 0.91 | AKT2 (0.47) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL17658820 | 0.91 | AKT2 (0.47) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL17658821 | 0.91 | AKT2 (0.47) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL23441917 | 0.90 | AKT1 (0.38) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL19928001 | 0.88 | AKT2 (0.50) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL19928009 | 0.88 | AKT2 (0.50) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL15887881 | 0.87 | AKT1 (0.41) | AKT1AKT2NPC1RAB9AKDM4E | |
| SCHEMBL23509625 | 0.86 | AKT1 (0.42) | AKT1AKT2NPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230015881-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE COMPOUND | GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD (CN) | 2023-01-19 | — | — | US | disclosed |
| WO-2021103769-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE COMPOUND | 广东阿格蕾雅光电材料有限公司 | 2021-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230015881-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE COMPOUND | BRD9, MRPL9, INTS9 | AKT1 3517/4885AKT2 3899/4885NPC1 3676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.